Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Obesity

Free Subscription Articles published in Lancet Retrieve available abstracts of 68 articles: HTML format Text format

Single Articles

October 2019
1. MYTTON OT, Fenton-Glynn C, Pawson E, Viner RM, et al
   Protecting children's rights: why governments must be bold to tackle childhood obesity.
   Lancet. 2019 Oct 10. pii: S0140-6736(19)32274.
   PubMed     Text format    
   
   
   
2. XIAO Y, Sun L
   Semaglutide in weight management.
   Lancet. 2019;394:1226.
   PubMed     Text format    
   
   
   
3. WILDING JPH
   Semaglutide in weight management - Author's reply.
   Lancet. 2019;394:1226-1227.
   PubMed     Text format    
   
   
   August 2019
4. BARNETT R
   Type 2 diabetes.
   Lancet. 2019;394:557.
   PubMed     Text format    
   
   
   
5. LEVAILLANT M, Lievre G, Baert G
   Ending diabetes in Mexico.
   Lancet. 2019;394:467-468.
   PubMed     Text format    
   
   
   July 2019
6. 
   The slowdown in eradicating hunger.
   Lancet. 2019;394:274.
   PubMed     Text format    
   
   
   April 2019
7. RENEHAN AG, Lloyd K, Renehan I
   Awareness of the link between obesity and cancer in UK school curricula.
   Lancet. 2019;393:1591-1592.
   PubMed     Text format    
   
   
   March 2019
8. MADSBAD S, Holst JJ
   Bariatric surgery-which procedure is the optimal choice?
   Lancet. 2019;393:1263-1264.
   PubMed     Text format    
   
   
   
9. MASA JF, Mokhlesi B, Benitez I, Gomez de Terreros FJ, et al
   Long-term clinical effectiveness of continuous positive airway pressure therapy versus non-invasive ventilation therapy in patients with obesity hypoventilation syndrome: a multicentre, open-label, randomised controlled trial.
   Lancet. 2019 Mar 29. pii: S0140-6736(18)32978.
   PubMed     Text format     Abstract available
   
   
   
10. MURPHY PB, Piper AJ, Hart N
    Obesity hypoventilation syndrome: is less really more?
    Lancet. 2019 Mar 29. pii: S0140-6736(19)30248.
    PubMed     Text format    
    
    
    
11. AZZOPARDI PS, Hearps SJC, Francis KL, Kennedy EC, et al
    Progress in adolescent health and wellbeing: tracking 12 headline indicators for 195 countries and territories, 1990-2016.
    Lancet. 2019;393:1101-1118.
    PubMed     Text format     Abstract available
    
    
    
12. ROBERT M, Espalieu P, Pelascini E, Caiazzo R, et al
    Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial.
    Lancet. 2019 Mar 6. pii: S0140-6736(19)30475.
    PubMed     Text format     Abstract available
    
    
    
13. THE LANCET
    Health and wellbeing in adolescence and early adulthood.
    Lancet. 2019;393:847.
    PubMed     Text format    
    
    
    February 2019
14. NUGENT R
    Rethinking systems to reverse the global syndemic.
    Lancet. 2019;393:726-728.
    PubMed     Text format    
    
    
    
15. DA SILVA JG
    Transforming food systems for better health.
    Lancet. 2019;393:e30-e31.
    PubMed     Text format    
    
    
    
16. MENDENHALL E, Singer M
    The global syndemic of obesity, undernutrition, and climate change.
    Lancet. 2019 Feb 11. pii: S0140-6736(19)30310.
    PubMed     Text format    
    
    
    January 2019
17. KLEINERT S, Horton R
    Obesity needs to be put into a much wider context.
    Lancet. 2019 Jan 25. pii: S0140-6736(18)33192.
    PubMed     Text format    
    
    
    
18. DAVIES R
    William Dietz: shaping science and policy on obesity.
    Lancet. 2019 Jan 25. pii: S0140-6736(19)30147.
    PubMed     Text format    
    
    
    
19. SWINBURN BA, Kraak VI, Allender S, Atkins VJ, et al
    The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report.
    Lancet. 2019 Jan 25. pii: S0140-6736(18)32822.
    PubMed     Text format    
    
    
    
20. THE LANCET
    2019: the year for nutrition.
    Lancet. 2019;393:200.
    PubMed     Text format    
    
    
    December 2018
21. SANYAL A, Charles ED, Neuschwander-Tetri BA, Loomba R, et al
    Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial.
    Lancet. 2018 Dec 13. pii: S0140-6736(18)31785.
    PubMed     Text format     Abstract available
    
    
    
22. WILLIAMS R, Alexander G, Aspinall R, Batterham R, et al
    Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK.
    Lancet. 2018;392:2398-2412.
    PubMed     Text format     Abstract available
    
    
    November 2018
23. UNAMUNO X, Fruhbeck G
    Lorcaserin: balancing efficacy with potential risks.
    Lancet. 2018;392:2239-2240.
    PubMed     Text format    
    
    
    October 2018
24. TAYLOR R, Adamson AJ, Sattar N, Lean MEJ, et al
    VLCD for weight loss and remission of type 2 diabetes? - Authors' reply.
    Lancet. 2018;392:1307.
    PubMed     Text format    
    
    
    
25. AHMAD N, Alfaris N
    VLCD for weight loss and remission of type 2 diabetes?
    Lancet. 2018;392:1306-1307.
    PubMed     Text format    
    
    
    
26. RALSTON J, Brinsden H, Buse K, Candeias V, et al
    Time for a new obesity narrative.
    Lancet. 2018 Oct 10. pii: S0140-6736(18)32537.
    PubMed     Text format    
    
    
    
27. BOHULA EA, Scirica BM, Inzucchi SE, McGuire DK, et al
    Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial.
    Lancet. 2018 Oct 3. pii: S0140-6736(18)32328.
    PubMed     Text format     Abstract available
    
    
    August 2018
28. O'NEIL PM, Birkenfeld AL, McGowan B, Mosenzon O, et al
    Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial.
    Lancet. 2018 Aug 16. pii: S0140-6736(18)31773.
    PubMed     Text format     Abstract available
    
    
    June 2018
29. RAYNER CK, Horowitz M
    Agonism of receptors in the gut-pancreas axis in type 2 diabetes: are two better than one?
    Lancet. 2018 Jun 22. pii: S0140-6736(18)30936.
    PubMed     Text format    
    
    
    
30. AMBERY P, Parker VE, Stumvoll M, Posch MG, et al
    MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study.
    Lancet. 2018 Jun 22. pii: S0140-6736(18)30726.
    PubMed     Text format     Abstract available
    
    
    May 2018
31. EZZATI M, Di Cesare M, Bentham J
    Determining the worldwide prevalence of obesity - Authors' reply.
    Lancet. 2018;391:1774.
    PubMed     Text format    
    
    
    
32. REILLY JJ, El-Hamdouchi A, Diouf A, Monyeki A, et al
    Determining the worldwide prevalence of obesity.
    Lancet. 2018;391:1773-1774.
    PubMed     Text format    
    
    
    
33. FLEMING TP, Watkins AJ, Velazquez MA, Mathers JC, et al
    Origins of lifetime health around the time of conception: causes and consequences.
    Lancet. 2018;391:1842-1852.
    PubMed     Text format     Abstract available
    
    
    March 2018
34. THOMPSON AJ, Baranzini SE, Geurts J, Hemmer B, et al
    Multiple sclerosis.
    Lancet. 2018 Mar 22. pii: S0140-6736(18)30481.
    PubMed     Text format     Abstract available
    
    
    
35. BUCHBINDER R, van Tulder M, Oberg B, Costa LM, et al
    Low back pain: a call for action.
    Lancet. 2018 Mar 20. pii: S0140-6736(18)30488.
    PubMed     Text format     Abstract available
    
    
    January 2018
36. ABDULHUSSEIN D, Amin E
    Translation of the link between cancer and obesity to patients.
    Lancet. 2018;391:121-122.
    PubMed     Text format    
    
    
    
37. SELBIE D
    Reducing childhood obesity in the UK.
    Lancet. 2018;391:26.
    PubMed     Text format    
    
    
    
38. BRAILLON A
    Reducing childhood obesity in the UK and France.
    Lancet. 2018;391:26.
    PubMed     Text format    
    
    
    November 2017
39. WILLIAMS R, Alexander G, Armstrong I, Baker A, et al
    Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK.
    Lancet. 2017 Nov 28. pii: S0140-6736(17)32866.
    PubMed     Text format     Abstract available
    
    
    October 2017
40. THE LANCET
    The link between cancer and obesity.
    Lancet. 2017;390:1716.
    PubMed     Text format    
    
    
    
41. 
    Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults.
    Lancet. 2017 Oct 10. pii: S0140-6736(17)32129.
    PubMed     Text format     Abstract available
    
    
    
42. DIETZ WH
    Double-duty solutions for the double burden of malnutrition.
    Lancet. 2017 Oct 10. pii: S0140-6736(17)32479.
    PubMed     Text format    
    
    
    September 2017
43. JURECIC A, Marchalik D
    On obesity: Roxane Gay's Hunger.
    Lancet. 2017;390:1577.
    PubMed     Text format    
    
    
    August 2017
44. THE LANCET
    The UK's inadequate plan for reducing childhood obesity.
    Lancet. 2017;390:822.
    PubMed     Text format    
    
    
    June 2017
45. ANGADI SS, Gaesser GA
    Body-mass index and all-cause mortality.
    Lancet. 2017;389:2285.
    PubMed     Text format    
    
    
    
46. DI ANGELANTONIO E, Bhupathiraju SN, Hu FB, Danesh J, et al
    Body-mass index and all-cause mortality - Authors' reply.
    Lancet. 2017;389:2285-2286.
    PubMed     Text format    
    
    
    
47. FLEGAL KM
    Body-mass index and all-cause mortality.
    Lancet. 2017;389:2284-2285.
    PubMed     Text format    
    
    
    
48. PEPPER DJ, Sun J, Suffredini AF, Kadri S, et al
    Body-mass index and all-cause mortality.
    Lancet. 2017;389:2284.
    PubMed     Text format    
    
    
    
49. VINER R, White B, Christie D
    Type 2 diabetes in adolescents: a severe phenotype posing major clinical challenges and public health burden.
    Lancet. 2017;389:2252-2260.
    PubMed     Text format     Abstract available
    
    
    April 2017
50. KIRCHHOF P
    The future of atrial fibrillation management: integrated care and stratified therapy.
    Lancet. 2017 Apr 28. pii: S0140-6736(17)31072.
    PubMed     Text format     Abstract available
    
    
    
51. AVEYARD P, Nickless A, Jebb S
    Obesity management in primary care - Authors' reply.
    Lancet. 2017;389:1606-1607.
    PubMed     Text format    
    
    
    
52. HIGUCHI A, Kami M
    Obesity management in primary care.
    Lancet. 2017;389:1606.
    PubMed     Text format    
    
    
    
53. STURGISS EA, Haesler E, Elmitt N, Douglas K, et al
    Obesity management in primary care.
    Lancet. 2017;389:1605.
    PubMed     Text format    
    
    
    
54. BOOTH HP, Gulliford MC
    Obesity management in primary care.
    Lancet. 2017;389:1605-1606.
    PubMed     Text format    
    
    
    February 2017
55. LE ROUX CW, Astrup A, Fujioka K, Greenway F, et al
    3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
    Lancet. 2017 Feb 22. pii: S0140-6736(17)30069.
    PubMed     Text format     Abstract available
    
    
    January 2017
56. STRINGHINI S, Carmeli C, Jokela M, Avendano M, et al
    Socioeconomic status and the 25 x 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1.7 million men and women.
    Lancet. 2017 Jan 31. pii: S0140-6736(16)32380.
    PubMed     Text format     Abstract available
    
    
    
57. THE LANCET
    Obesity and diabetes in 2017: a new year.
    Lancet. 2017;389:1.
    PubMed     Text format    
    
    
    November 2016
58. ROYO-BORDONADA MA
    Setting up childhood obesity policies in Europe.
    Lancet. 2016;388:2475.
    PubMed     Text format    
    
    
    October 2016
59. AVEYARD P, Lewis A, Tearne S, Hood K, et al
    Screening and brief intervention for obesity in primary care: a parallel, two-arm, randomised trial.
    Lancet. 2016 Oct 21. pii: S0140-6736(16)31893.
    PubMed     Text format     Abstract available
    
    
    
60. SWINBURN B, Arroll B
    Rethinking primary care systems for obesity.
    Lancet. 2016 Oct 21. pii: S0140-6736(16)31913.
    PubMed     Text format    
    
    
    
61. AVEYARD P, Lewis A, Tearne S, Hood K, et al
    Screening and brief intervention for obesity in primary care: a parallel, two-arm, randomised trial.
    Lancet. 2016 Oct 21. pii: S0140-6736(16)31893.
    PubMed     Text format     Abstract available
    
    
    
62. SIGMON SC
    Additive burdens of malnutrition, poverty, and substance abuse.
    Lancet. 2016;388:1879-1880.
    PubMed     Text format    
    
    
    
63. LI B, Lin R, Liu W, Chen J, et al
    Differences in perceived causes of childhood obesity between migrant and local communities in China: a qualitative study.
    Lancet. 2016;388 Suppl 1:S3.
    PubMed     Text format     Abstract available
    
    
    September 2016
64. LI F, Liu Y, Zhu W, Harmer P, et al
    China's challenges in promoting physical activity and fitness.
    Lancet. 2016;388:1278-9.
    PubMed     Text format    
    
    
    August 2016
65. MANN J, Morenga LT, McLean R, Swinburn B, et al
    Dietary guidelines on trial: the charges are not evidence based.
    Lancet. 2016;388:851-3.
    PubMed     Text format    
    
    
    
66. FREEDHOFF Y, Hall KD
    Weight loss diet studies: we need help not hype.
    Lancet. 2016;388:849-51.
    PubMed     Text format    
    
    
    
67. BERRIGAN D, Troiano RP, Graubard BI
    BMI and mortality: the limits of epidemiological evidence.
    Lancet. 2016;388:734-6.
    PubMed     Text format    
    
    
    July 2016
68. O'DONNELL MJ, Chin SL, Rangarajan S, Xavier D, et al
    Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.
    Lancet. 2016 Jul 15. pii: S0140-6736(16)30506.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obesity is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: